LivingGLP1
Study S001214

Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status in Female Patients With Type 2 Diabetes and Obesity

Registration

Registration
NCT02118376
Study type
INTERVENTIONAL
Masking
NONE
Status
UNKNOWN
Enrollment
20
Start
2014-08
Primary completion
2014-12
Lead sponsor
Shanghai 10th People's Hospital
Conditions
Obesity
Interventions
DRUG:Exenatide
Results posted
FALSE

Registered primary outcomes

  • Dual energy X-ray absorptiometry [3 month]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0026149New association of bone morphogenetic protein 4 concentrations with fat distribution in obesity and Exenatide intervention on it.
Wang X, Lipids in health and disease
2017Other trialPMID 28376799DOIcites ClinicalTrials.gov:NCT02118376; registry reference DERIVED:28376799